Adulthood Exposure to Lipopolysaccharide Exacerbates the Neurotoxic and Inflammatory Effects of Rotenone in the Substantia Nigra.

Chun Huang, Li Zhu, Huan Li, Fu-Guo Shi, Guo-Qing Wang, Yi-Zheng Wei, Jie Liu, Feng Zhang
Author Information
  1. Chun Huang: Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical UniversityZunyi, China.
  2. Li Zhu: Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical UniversityZunyi, China.
  3. Huan Li: Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical UniversityZunyi, China.
  4. Fu-Guo Shi: Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical UniversityZunyi, China.
  5. Guo-Qing Wang: Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical UniversityZunyi, China.
  6. Yi-Zheng Wei: Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical UniversityZunyi, China.
  7. Jie Liu: Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical UniversityZunyi, China.
  8. Feng Zhang: Key Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical UniversityZunyi, China.

Abstract

Parkinson's disease (PD) is the second most neurodegenerative disorder with a regional decrease of dopamine (DA) neurons in the substantia nigra (SN). Despite intense exploration, the etiology of PD progressive process remains unclear. This study was to investigate the synergistic effects of systemic inflammation of lipopolysaccharide (LPS) and neurotoxicity of rotenone (ROT) on exacerbating DA neuron lesion. Male SD adulthood rats received a single intraperitoneal injection of LPS. Seven months later, rats were subcutaneously given ROT five times a week for consecutive 4 weeks. Rat behavior changes were assessed via rotarod and open-field tests. Brain SN was immunostained to evaluate DA neuronal loss and microglia activation. Striatum DA and its metabolites levels were determined by high performance liquid chromatography (HPLC) coupled with electrochemistry. The protein levels of ��-synuclein (��-Syn), inflammatory factors and mitogen-activated protein kinase (MAPK) pathway activation were detected by western blotting analysis. Results indicated that no significant difference between the control and LPS alone groups was shown. Compared with ROT alone group, LPS combined with ROT significantly reduced motor activity and induced SN DA neurons loss accompanied by the decreased contents of striatum DA and its metabolites. Furthermore, LPS together with ROT enhanced microglia activation and the increased expressions of ��-Syn and inflammatory factors and also MAPK signaling pathway activation. However, LPS alone had no significant effects on the above parameters. These findings suggest that adulthood exposure to LPS exacerbates the neurotoxic and inflammatory effects of ROT in the SN.

Keywords

References

  1. Brain Res. 2011 Jan 12;1368:254-63 [PMID: 20951685]
  2. Immunology. 2010 Feb;129(2):154-69 [PMID: 20561356]
  3. J Neurotrauma. 2001 Nov;18(11):1207-16 [PMID: 11721739]
  4. Neurobiol Dis. 2016 Sep;93:96-114 [PMID: 27151770]
  5. Nat Rev Neurosci. 2007 Jan;8(1):57-69 [PMID: 17180163]
  6. Environ Health Perspect. 2011 Jun;119(6):807-14 [PMID: 21245015]
  7. Cell Mol Life Sci. 2015 Dec;72(24):4795-805 [PMID: 26403788]
  8. Autoimmun Rev. 2016 Dec;15(12):1210 [PMID: 27725149]
  9. Exp Neurol. 2006 Jun;199(2):499-512 [PMID: 16504177]
  10. J Comp Neurol. 2004 Oct 25;478(4):418-26 [PMID: 15384065]
  11. Environ Health Perspect. 2003 Jun;111(8):1065-73 [PMID: 12826478]
  12. Environ Health Perspect. 2006 Feb;114(2):156-64 [PMID: 16451848]
  13. Neurobiol Dis. 2009 May;34(2):279-90 [PMID: 19385059]
  14. Arch Oral Biol. 2017 Jan;73:151-160 [PMID: 27770641]
  15. Curr Opin Pharmacol. 2016 Feb;26:54-60 [PMID: 26498406]
  16. J Pharmacol Exp Ther. 2010 Jun;333(3):822-33 [PMID: 20190013]
  17. Front Cell Neurosci. 2015 Feb 02;9:28 [PMID: 25698933]
  18. FASEB J. 2006 Dec;20(14):2496-511 [PMID: 17142799]
  19. J Neuroinflammation. 2016 Jun 14;13(1):148 [PMID: 27301644]
  20. Eur J Epidemiol. 2011 Jul;26(7):547-55 [PMID: 21505849]
  21. J Neuroinflammation. 2015 Jan 17;12:9 [PMID: 25595674]
  22. Free Radic Biol Med. 2012 Jan 15;52(2):303-13 [PMID: 22094225]
  23. Exp Neurol. 2004 Jun;187(2):418-29 [PMID: 15144868]
  24. Parkinsonism Relat Disord. 2012 Jan;18 Suppl 1:S183-5 [PMID: 22166429]
  25. J Neurosci. 2008 Oct 22;28(43):10825-34 [PMID: 18945890]
  26. J Neurochem. 2007 Oct;103(1):303-11 [PMID: 17587308]
  27. Brain Behav Immun. 2004 Sep;18(5):407-13 [PMID: 15265532]
  28. J Neurosci. 2002 Feb 1;22(3):782-90 [PMID: 11826108]
  29. J Neurosci. 2003 Feb 15;23(4):1228-36 [PMID: 12598611]
  30. Trends Neurosci. 2001 May;24(5):245-7 [PMID: 11311359]
  31. Behav Brain Res. 2014 Feb 1;259:70-7 [PMID: 24183944]
  32. Dev Neurosci. 2013;35(2-3):155-71 [PMID: 23446007]
  33. Neurobiol Dis. 2011 Dec;44(3):304-16 [PMID: 21798348]
  34. Environ Health Perspect. 2011 Jun;119(6):866-72 [PMID: 21269927]
  35. Mediators Inflamm. 2016;2016:7216912 [PMID: 27524868]
  36. Exp Neurol. 2004 Dec;190(2):373-83 [PMID: 15530876]
  37. J Neurosci. 2011 Jan 19;31(3):1081-92 [PMID: 21248133]
  38. Drug Des Devel Ther. 2015 Oct 07;9:5499-510 [PMID: 26504373]

Word Cloud

Created with Highcharts 10.0.0LPSDAROTSNactivationeffectsmicrogliainflammatoryalonediseasePDneuronslipopolysaccharideneurotoxicityrotenoneadulthoodratslossmetaboliteslevelsprotein��-SynfactorsMAPKpathwaysignificantParkinson'ssecondneurodegenerativedisorderregionaldecreasedopaminesubstantianigraDespiteintenseexplorationetiologyprogressiveprocessremainsunclearstudyinvestigatesynergisticsystemicinflammationexacerbatingneuronlesionMaleSDreceivedsingleintraperitonealinjectionSevenmonthslatersubcutaneouslygivenfivetimesweekconsecutive4weeksRatbehaviorchangesassessedviarotarodopen-fieldtestsBrainimmunostainedevaluateneuronalStriatumdeterminedhighperformanceliquidchromatographyHPLCcoupledelectrochemistry��-synucleinmitogen-activatedkinasedetectedwesternblottinganalysisResultsindicateddifferencecontrolgroupsshownComparedgroupcombinedsignificantlyreducedmotoractivityinducedaccompanieddecreasedcontentsstriatumFurthermoretogetherenhancedincreasedexpressionsalsosignalingHoweverparametersfindingssuggestexposureexacerbatesneurotoxicAdulthoodExposureLipopolysaccharideExacerbatesNeurotoxicInflammatoryEffectsRotenoneSubstantiaNigraParkinson���s

Similar Articles

Cited By